KCC Clinical Trials
RENAL
(click on the protocol number below for additional information on that trial)
09F.463 : Renal
Purpose: To determine if patients with advanced transitional cell carcinoma treated with b evacizumab, gemcitabine and cisplatin will have increased overall survival when compared to patients treated with gemcitabine, cisplatin, and placebo.
Title: A Randomized Double-Blinded Phase III Study Comparing Gemcitabine, Cisplatin, and Bevacizumab to Gemcitabine, Cisplantin, and Placebo in Patients with Advanced Transitional Cell Carcinoma (CALGB 90601) |
Make
another protocol list selection
|
